These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16970914)

  • 1. Enhancement of insulin signaling pathway in adipocytes by oxovanadium(IV) complexes.
    Basuki W; Hiromura M; Adachi Y; Tayama K; Hattori M; Sakurai H
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1163-70. PubMed ID: 16970914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action mechanism of bis(allixinato)oxovanadium(IV) as a novel potent insulin-mimetic complex: regulation of GLUT4 translocation and FoxO1 transcription factor.
    Hiromura M; Nakayama A; Adachi Y; Doi M; Sakurai H
    J Biol Inorg Chem; 2007 Nov; 12(8):1275-87. PubMed ID: 17805585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vanadyl (VO2+) chelate bis(acetylacetonato)oxovanadium(IV) potentiates tyrosine phosphorylation of the insulin receptor.
    Ou H; Yan L; Mustafi D; Makinen MW; Brady MJ
    J Biol Inorg Chem; 2005 Dec; 10(8):874-86. PubMed ID: 16235045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin and chromium picolinate induce translocation of CD36 to the plasma membrane through different signaling pathways in 3T3-L1 adipocytes, and with a differential functionality of the CD36.
    Wang Y; Van Oort MM; Yao M; Van der Horst DJ; Rodenburg KW
    Biol Trace Elem Res; 2011 Sep; 142(3):735-47. PubMed ID: 20721637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism.
    Chen G; Liu P; Pattar GR; Tackett L; Bhonagiri P; Strawbridge AB; Elmendorf JS
    Mol Endocrinol; 2006 Apr; 20(4):857-70. PubMed ID: 16339278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chromium picolinate on glucose uptake in insulin-resistant 3T3-L1 adipocytes involve activation of p38 MAPK.
    Wang YQ; Yao MH
    J Nutr Biochem; 2009 Dec; 20(12):982-91. PubMed ID: 19195868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of insulin-like growth factor type 1 receptor and protein kinase Cdelta in bis(maltolato)oxovanadium(IV)-induced phosphorylation of protein kinase B in HepG2 cells.
    Mehdi MZ; Vardatsikos G; Pandey SK; Srivastava AK
    Biochemistry; 2006 Sep; 45(38):11605-15. PubMed ID: 16981720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
    Yasui H; Tamura A; Takino T; Sakurai H
    J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-stimulated fusion of GLUT4 vesicles to plasma membrane is dependent on wortmannin-sensitive insulin signaling pathway in 3T3-L1 adipocytes.
    Kawaguchi T; Tamori Y; Yoshikawa M; Kanda H; Kasuga M
    Kobe J Med Sci; 2008 Oct; 54(4):E209-16. PubMed ID: 19258741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulinomimetic Zn complex (Zn(opt)2) enhances insulin signaling pathway in 3T3-L1 adipocytes.
    Basuki W; Hiromura M; Sakurai H
    J Inorg Biochem; 2007 Apr; 101(4):692-9. PubMed ID: 17316811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-derived growth factor (PDGF) stimulates glucose transport in 3T3-L1 adipocytes overexpressing PDGF receptor by a pathway independent of insulin receptor substrates.
    Whiteman EL; Chen JJ; Birnbaum MJ
    Endocrinology; 2003 Sep; 144(9):3811-20. PubMed ID: 12933652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new oxovanadium complex enhances renal function by improving insulin signaling pathway in diabetic mice.
    Liu Y; Chen DD; Xing YH; Ge N; Zhang Y; Liu J; Zou W
    J Diabetes Complications; 2014; 28(3):265-72. PubMed ID: 24636761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of intracellular calcium depletion on insulin signaling in 3T3-L1 adipocytes.
    Worrall DS; Olefsky JM
    Mol Endocrinol; 2002 Feb; 16(2):378-89. PubMed ID: 11818508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.
    Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM
    J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S(2)O(2)) coordination mode.
    Takeshita S; Kawamura I; Yasuno T; Kimura C; Yamamoto T; Seki J; Tamura A; Sakurai H; Goto T
    J Inorg Biochem; 2001 Jun; 85(2-3):179-86. PubMed ID: 11410238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y impairs insulin-stimulated translocation of glucose transporter 4 in 3T3-L1 adipocytes through the Y1 receptor.
    Gericke MT; Schröder T; Kosacka J; Nowicki M; Klöting N; Spanel-Borowski K
    Mol Cell Endocrinol; 2012 Jan; 348(1):27-32. PubMed ID: 21801810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoA-IV improves insulin sensitivity and glucose uptake in mouse adipocytes via PI3K-Akt Signaling.
    Li X; Wang F; Xu M; Howles P; Tso P
    Sci Rep; 2017 Jan; 7():41289. PubMed ID: 28117404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes.
    Wada T; Hori S; Sugiyama M; Fujisawa E; Nakano T; Tsuneki H; Nagira K; Saito S; Sasaoka T
    Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E881-8. PubMed ID: 20071559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan increases localization of glucose transporter 4 to the plasma membrane and increases glucose uptake via peroxisome proliferator-activated receptor γ in 3T3-L1 adipocytes.
    Furukawa H; Mawatari K; Koyama K; Yasui S; Morizumi R; Shimohata T; Harada N; Takahashi A; Nakaya Y
    Eur J Pharmacol; 2011 Jun; 660(2-3):485-91. PubMed ID: 21514293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.